Quantum-Si (NASDAQ:QSI) Earns Buy Rating from Analysts at Alliance Global Partners

Research analysts at Alliance Global Partners assumed coverage on shares of Quantum-Si (NASDAQ:QSIGet Free Report) in a research note issued on Friday,Briefing.com Automated Import reports. The firm set a “buy” rating and a $3.75 price target on the stock. Alliance Global Partners’ price objective suggests a potential upside of 97.37% from the company’s previous close.

A number of other equities research analysts have also recently commented on the stock. Canaccord Genuity Group decreased their target price on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Wednesday, November 13th. HC Wainwright restated a “buy” rating and set a $5.50 price target on shares of Quantum-Si in a research note on Tuesday, January 14th.

View Our Latest Report on QSI

Quantum-Si Price Performance

NASDAQ:QSI opened at $1.90 on Friday. Quantum-Si has a 52 week low of $0.61 and a 52 week high of $5.77. The firm has a 50 day moving average of $2.14 and a 200 day moving average of $1.35. The stock has a market capitalization of $271.15 million, a price-to-earnings ratio of -2.97 and a beta of 2.70.

Insider Activity at Quantum-Si

In other Quantum-Si news, Director Jonathan M. Rothberg sold 3,506,267 shares of Quantum-Si stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $3.34, for a total transaction of $11,710,931.78. Following the completion of the sale, the director now directly owns 1,250,000 shares in the company, valued at approximately $4,175,000. The trade was a 73.72 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 30.04% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in QSI. Barclays PLC grew its position in Quantum-Si by 210.5% during the 3rd quarter. Barclays PLC now owns 196,826 shares of the company’s stock worth $173,000 after purchasing an additional 133,438 shares during the period. Geode Capital Management LLC boosted its stake in shares of Quantum-Si by 6.7% in the third quarter. Geode Capital Management LLC now owns 2,316,921 shares of the company’s stock worth $2,044,000 after buying an additional 145,091 shares during the last quarter. Abel Hall LLC acquired a new stake in Quantum-Si during the fourth quarter worth about $28,000. SG Americas Securities LLC purchased a new position in Quantum-Si during the third quarter valued at approximately $53,000. Finally, XTX Topco Ltd lifted its holdings in Quantum-Si by 81.3% in the third quarter. XTX Topco Ltd now owns 43,812 shares of the company’s stock valued at $39,000 after acquiring an additional 19,651 shares during the period. Hedge funds and other institutional investors own 39.90% of the company’s stock.

About Quantum-Si

(Get Free Report)

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.

Recommended Stories

Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.